NEFL and early-onset autosomal dominant Alzheimer disease: Serum NfL (sNfL) shows promise as a blood biomarker for monitoring neurodegenerative and neuroinflammatory diseases like Alzheimer’s disease and multiple sclerosis, and possible also for cerebral small vessel disease (cSVD)2,3.